Publications
Found 1 results
Filters: Author is H. Şamlı [Clear All Filters]
“Vascular endothelial growth factor gene 1154 G/A, 2578 C/A, 460 C/T, 936 C/T polymorphisms and association with recurrent pregnancy losses”, vol. 11, pp. 4739-4745, 2012.
, Awata T, Inoue K, Kurihara S, Ohkubo T, et al. (2002). A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51: 1635-1639.
http://dx.doi.org/10.2337/diabetes.51.5.1635
PMid:11978667
Bikfalvi A (2004). Recent developments in the inhibition of angiogenesis: examples from studies on platelet factor-4 and the VEGF/VEGFR system. Biochem. Pharmacol. 68: 1017-1021.
http://dx.doi.org/10.1016/j.bcp.2004.05.030
PMid:15313395
Brogan IJ, Khan N, Isaac K, Hutchinson JA, et al. (1999). Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene. Hum. Immunol. 60: 1245-1249.
http://dx.doi.org/10.1016/S0198-8859(99)00132-9
Carmeliet P, Ferreira V, Breier G, Pollefeyt S, et al. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439.
http://dx.doi.org/10.1038/380435a0
PMid:8602241
Coulam CB and Jeyendran RS (2008). Vascular endothelial growth factor gene polymorphisms and recurrent pregnancy loss. Am. J. Reprod. Immunol. 59: 301-305.
http://dx.doi.org/10.1111/j.1600-0897.2007.00515.x
PMid:18294357
Ferrara N, Carver-Moore K, Chen H, Dowd M, et al. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442.
http://dx.doi.org/10.1038/380439a0
PMid:8602242
Ferrara N, Gerber HP and LeCouter J (2003). The biology of VEGF and its receptors. Nat. Med. 9: 669-676.
http://dx.doi.org/10.1038/nm0603-669
PMid:12778165
Harry LE and Paleolog EM (2003). From the cradle to the clinic: VEGF in developmental, physiological, and pathological angiogenesis. Birth Defects Res. C Embryo Today 69: 363-374.
http://dx.doi.org/10.1002/bdrc.10024
PMid:14745976
Hellgren M (1996). Hemostasis during pregnancy and puerperium. Haemostasis 26: 224-247.
Jin Q, Hemminki K, Enquist K, Lenner P, et al. (2005). Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin. Cancer Res. 11: 3647-3653.
http://dx.doi.org/10.1158/1078-0432.CCR-04-1803
PMid:15897560
Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, et al. (2003). A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int. J. Cancer 106: 468-471.
http://dx.doi.org/10.1002/ijc.11238
PMid:12845639
Lee HH, Hong SH, Shin SJ, Ko JJ, et al. (2010). Association study of vascular endothelial growth factor polymorphisms with the risk of recurrent spontaneous abortion. Fertil. Steril. 93: 1244-1247.
http://dx.doi.org/10.1016/j.fertnstert.2008.11.017
PMid:19131057
Letsky EA and Swiet M (1994). Maternal Hemostasis: Coagulation Problems of Pregnancy. In: Thrombosis and Hemorrhage (Loscalzo J and Schafer AI, eds.). Blackwell Scientific Publications, Boston, 965-998.
Li TC, Makris M, Tomsu M, Tuckerman E, et al. (2002). Recurrent miscarriage: aetiology, management and prognosis. Hum. Reprod. Update 8: 463-481.
http://dx.doi.org/10.1093/humupd/8.5.463
PMid:12398226
Liu Q, Li Y, Zhao J, Sun DL, et al. (2009). Association of polymorphisms -1154G/A and -2578C/A in the vascular endothelial growth factor gene with decreased risk of endometriosis in Chinese women. Hum. Reprod. 24: 2660-2666.
http://dx.doi.org/10.1093/humrep/dep208
PMid:19531502
Mohammadi M, Ollier WE and Hutchinson IV (2003). A functional association study of VEGF gene promoter polymorphisms with VEGF expression by stimulated pbm cells. Hum. Immunol. 64 (Suppl 10): S125.
http://dx.doi.org/10.1016/j.humimm.2003.08.234
NCICB (2012). National Cancer Institute Web Services. Available at [http://omim.org/entry/192240]. Accessed May 15, 2011.
Papazoglou D, Galazios G, Papatheodorou K, Liberis V, et al. (2005). Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancy loss. Fertil. Steril. 83: 959-963.
http://dx.doi.org/10.1016/j.fertnstert.2004.12.017
PMid:15820807
Regan L (1998). Overview of recurrent miscarriage. Gynaecol. Forum 3: 3-7.
Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, et al. (2000). A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J. Vasc. Res. 37: 443-448.
http://dx.doi.org/10.1159/000054076
PMid:11146397
Rowe AJ, Wulff C and Fraser HM (2003). Localization of mRNA for vascular endothelial growth factor (VEGF), angiopoietins and their receptors during the peri-implantation period and early pregnancy in marmosets (Callithrix jacchus). Reproduction 126: 227-238.
http://dx.doi.org/10.1530/rep.0.1260227
PMid:12887279
Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, et al. (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66.
http://dx.doi.org/10.1038/376062a0
PMid:7596435
te Velde EA, Exalto N, Hesseling P and van der Linden HC (1997). First trimester development of human chorionic villous vascularization studied with CD34 immunohistochemistry. Hum. Reprod. 12: 1577-1581.
http://dx.doi.org/10.1093/humrep/12.7.1577
PMid:9262300
Torry DS, Hinrichs M and Torry RJ (2004). Determinants of placental vascularity. Am. J. Reprod. Immunol. 51: 257-268.
http://dx.doi.org/10.1111/j.1600-0897.2004.00154.x
PMid:15212678
Watson CJ, Webb NJ, Bottomley MJ and Brenchley PE (2000). Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12: 1232-1235.
http://dx.doi.org/10.1006/cyto.2000.0692
PMid:10930302
Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, et al. (1988). Incidence of early loss of pregnancy. N. Engl. J. Med. 319: 189-194.
http://dx.doi.org/10.1056/NEJM198807283190401
PMid:3393170
Yancopoulos GD, Davis S, Gale NW, Rudge JS, et al. (2000). Vascular-specific growth factors and blood vessel formation. Nature 407: 242-248.
http://dx.doi.org/10.1038/35025215
PMid:11001067
Yang B, Cross DF, Ollerenshaw M, Millward BA, et al. (2003). Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. J. Diabetes Complications 17: 1-6.
http://dx.doi.org/10.1016/S1056-8727(02)00181-2
Zygmunt M, Herr F, Munstedt K, Lang U, et al. (2003). Angiogenesis and vasculogenesis in pregnancy. Eur. J Obstet. Gynecol. Reprod. Biol. 110 (Suppl 1): S10-S18.
http://dx.doi.org/10.1016/S0301-2115(03)00168-4